Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.96%
1,050.64
+20.24
+1.96%
1,030.401,038.581,051.411,035.31
SIXC
Communications
SIXC
Communications
SIXC
+0.26%
583.09
+1.54
+0.26%
581.55581.55588.95580.07
SIXE
Energy
SIXE
Energy
SIXE
-0.19%
1,278.14
-2.37
-0.19%
1,280.511,276.071,284.111,270.93
SIXI
Industrials
SIXI
Industrials
SIXI
+0.77%
1,667.58
+12.69
+0.77%
1,654.891,661.281,676.931,658.69
SIXM
Financials
SIXM
Financials
SIXM
+0.19%
609.36
+1.15
+0.19%
608.21610.01616.39604.82
SIXR
Staples
SIXR
Staples
SIXR
+0.47%
825.26
+3.82
+0.47%
821.44825.11826.13814.89
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.27%
198.93
+0.54
+0.27%
198.39198.39199.86197.46
SIXT
Technology
SIXT
Technology
SIXT
+0.25%
2,750.56
+6.97
+0.25%
2,743.592,763.922,779.962,746.33
SIXU
Utilities
SIXU
Utilities
SIXU
+0.44%
918.24
+4.06
+0.44%
914.18917.51924.94917.14
SIXV
Health care
SIXV
Health care
SIXV
+0.77%
1,476.68
+11.29
+0.77%
1,465.391,470.631,483.871,470.63
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.88%
2,237.25
+19.59
+0.88%
2,217.662,241.932,262.302,226.34
CTNM:NASDAQ
Contineum Therapeutics Inc
$13.20
+7.10%
(+0.88) 1D
Mar 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTNM...
Open
$12.46
High
$13.59
Low
$12.46
Mkt. cap
494.33M
Avg. vol.
314.42K
Volume
94.14K
52-wk high
$16.30
52-wk low
$3.35
EPS
-$2.17
Shares outstanding
32.67M
No. of employees
51
News stories
From sources across the web
About Contineum Therapeutics Inc
CEO-
Employees51
Founded2009
Headquarters-
SectorPharmaceutical industry
Last report
Mar 5, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.49/ (-0.39 est.)USD
-26.10%miss
Revenue / Estimate
-/ (5.00M est.)USD
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
13.71M
13.58M
10.50M
12.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.40M
4.32M
4.43M
5.12M
Operating expense
18.11M
17.90M
14.93M
17.12M
Total operating expenses
18.11M
17.90M
14.93M
17.12M
Operating income
-18.11M
-17.90M
-14.93M
-17.12M
Other non operating income
-130.00K
-167.00K
183.00K
-51.00K
EBT including unusual items
-15.99M
-16.04M
-12.79M
-15.16M
EBT excluding unusual items
-15.99M
-16.04M
-12.79M
-15.16M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15.99M
-16.04M
-12.79M
-15.16M
Net profit margin
-
-
-
-
Earnings per share
-0.62
-0.62
-0.45
-0.49
Interest and investment income
2.25M
2.03M
1.96M
2.01M
Interest expense
-
-
-
-
Net interest expenses
2.25M
2.03M
1.96M
2.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.03M
-17.82M
-14.85M
-17.03M
Gain or loss from assets sale
67.00K
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more